NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.27% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.89% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 2.56% |
| CGEM | Cullinan Oncology LLC | Healthcare | Biotechnology | 2.51% |
| VERA | Vera Therapeutics Inc | Healthcare | Biotechnology | 2.28% |
| SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 1.85% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 1.77% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 1.53% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.51% |
| MRUS | Merus BV | Healthcare | Biotechnology | 1.51% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 1.45% |
| GERN | Geron Corporation | Healthcare | Biotechnology | 1.45% |
| KROS | Keros Therapeutics Inc | Healthcare | Biotechnology | 1.45% |
| KURA | Kura Oncology Inc | Healthcare | Biotechnology | 1.39% |
| MGNX | MacroGenics Inc | Healthcare | Biotechnology | 1.32% |
| BCYC | Bicycle Therapeutics Ltd | Healthcare | Biotechnology | 1.28% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.28% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.24% |
| IGMS | IGM Biosciences Inc | Healthcare | Biotechnology | 1.22% |
| MLYS | Mineralys Therapeutics Inc. Common Stock | Healthcare | Biotechnology | 1.22% |
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.